Check out the best moments from Friday night's NBA action, including brilliant performances from Donovan Mitchell, Joel ...
Banks, fintechs and emerging digital asset firms are all working to build systems that are faster, more accessible and more ...
GlobalData on MSN
Sanofi shares fall 6% after double setback for MS drug tolebrutinib
The FDA has delayed tolebrutinib’s review date again, as Sanofi also posted a Phase III failure for the MS candidate.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback